Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00621426 · ClinicalTrials.gov registry record
T-Wave Alternans in Dialysis Patients
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 40
- Enrollment target
NCT00621426 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 40 participants.
The verdict
NCT00621426 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
Sudden cardiac death due to arrhythmia is the leading cause of death in end-stage renal disease (ESRD) patients treated with hemodialysis (HD). As it is anticipated that the number of individuals with ESRD will exceed 1.2 million in the next 20 years, sudden death in this population has enormous public health impact. Research has shown that arrhythmic events are temporally associated with longer periods between HD with a three-fold risk of events in the 12 hours preceding the longest inter-dialysis interval. The exact cause of these findings is unknown.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2007-04 |
| Est. Completion | 2008-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00621426
The ClinicalTrials.gov registry entry for NCT00621426 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00621426 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00621426 about?
NCT00621426 is a clinical study titled "T-Wave Alternans in Dialysis Patients". Sudden cardiac death due to arrhythmia is the leading cause of death in end-stage renal disease (ESRD) patients treated with hemodialysis (HD). As it is anticipated that the number of individuals with ESRD will exceed 1.2 million in the next 20 years, sudden death in this population has enormous pub...
What is the current status of trial NCT00621426?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2007-04. Estimated completion is 2008-05.
Who is sponsoring clinical trial NCT00621426?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.